Diabetes-type-specific thyroid safety of GLP-1 receptor agonists: evidence from a large real-world cohort
Therapeutic Advances in Endocrinology and Metabolism
Published online on June 30, 2026
Abstract
Therapeutic Advances in Endocrinology and Metabolism, Volume 17, January-December 2026.
Background:Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used across the glycemic spectrum, yet their thyroid safety profile remains debated. Prior studies have shown inconsistent findings, and evidence across prediabetes, type 1 ...
Background:Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used across the glycemic spectrum, yet their thyroid safety profile remains debated. Prior studies have shown inconsistent findings, and evidence across prediabetes, type 1 ...